{"text": "compared to non-obese patients.\n\nPharmacokinetics and Efficacy in Obese Patients\n\nObesity is a growing concern worldwide, affecting approximately 39% of\n\nadults in the United States (CDC). The impact of weight on antipsychotic\n\npharmacokinetics and efficacy has been an area of interest for researchers.\n\nThis section will explore the effects of weight on antipsychotics, focusing on\n\npharmacokinetics and efficacy in obese patients.\n\nNew header (similar to existing header)", "embedding": []}